ICRA forecasts single digit moderate growth for Indian pharma. Bengaluru, Apr 2 (UNI) The Indian pharma industry is likely to witness a single digit moderate growth on the back of slowing growth from the US given the relatively moderate proportion of large size drugs going off patent. According to a ...
Read more: ICRA forecasts single digit moderate growth for Indian pharma